These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20485730)

  • 21. Antifungal activities of extracts from Thai medicinal plants against opportunistic fungal pathogens associated with AIDS patients.
    Phongpaichit S; Subhadhirasakul S; Wattanapiromsakul C
    Mycoses; 2005 Sep; 48(5):333-8. PubMed ID: 16115104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of multidrug resistance in pathogenic fungi.
    Morschhäuser J
    Fungal Genet Biol; 2010 Feb; 47(2):94-106. PubMed ID: 19665571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biology and chemistry of antifungal agents: a review.
    Kathiravan MK; Salake AB; Chothe AS; Dudhe PB; Watode RP; Mukta MS; Gadhwe S
    Bioorg Med Chem; 2012 Oct; 20(19):5678-98. PubMed ID: 22902032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A new problem: multiresistant fungi].
    Wehr A
    Dtsch Med Wochenschr; 1997 Mar; 122(11):A9. PubMed ID: 9102278
    [No Abstract]   [Full Text] [Related]  

  • 25. Plant phenolics and terpenoids as adjuvants of antibacterial and antifungal drugs.
    Zacchino SA; Butassi E; Liberto MD; Raimondi M; Postigo A; Sortino M
    Phytomedicine; 2017 Dec; 37():27-48. PubMed ID: 29174958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic and mathematical inactivation studies of food spoilage fungi.
    Brul S; Klis FM
    Fungal Genet Biol; 1999; 27(2-3):199-208. PubMed ID: 10441445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and structure elucidation of parnafungins C and D, isoxazolidinone-containing antifungal natural products.
    Overy D; Calati K; Kahn JN; Hsu MJ; Martín J; Collado J; Roemer T; Harris G; Parish CA
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1224-7. PubMed ID: 19147347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal agents: mode of action in yeast cells.
    Carrillo-Muñoz AJ; Giusiano G; Ezkurra PA; Quindós G
    Rev Esp Quimioter; 2006 Jun; 19(2):130-9. PubMed ID: 16964330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida.
    Ahmad A; Khan A; Manzoor N; Khan LA
    Microb Pathog; 2010 Jan; 48(1):35-41. PubMed ID: 19835945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies in the discovery of novel antifungal scaffolds.
    Liu N; Wang C; Su H; Zhang W; Sheng C
    Future Med Chem; 2016 Aug; 8(12):1435-54. PubMed ID: 27463376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development.
    Ablordeppey SY; Fan P; Ablordeppey JH; Mardenborough L
    Curr Med Chem; 1999 Dec; 6(12):1151-95. PubMed ID: 10519919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal activity of 2α,3β-functionalized steroids stereoselectively increases with the addition of oligosaccharides.
    Cammarata A; Upadhyay SK; Jursic BS; Neumann DM
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7379-86. PubMed ID: 22047693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural Sources as Innovative Solutions Against Fungal Biofilms.
    Girardot M; Imbert C
    Adv Exp Med Biol; 2016; 931():105-25. PubMed ID: 27115410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents.
    Emami S; Foroumadi A; Falahati M; Lotfali E; Rajabalian S; Ebrahimi SA; Farahyar S; Shafiee A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):141-6. PubMed ID: 18032039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species.
    Prado-Prado FJ; Borges F; Perez-Montoto LG; González-Díaz H
    Eur J Med Chem; 2009 Oct; 44(10):4051-6. PubMed ID: 19467743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility testing in fungi: a global perspective on a variety of methods.
    Lass-Flörl C; Perkhofer S; Mayr A
    Mycoses; 2010 Jan; 53(1):1-11. PubMed ID: 20078786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empirical antibacterial drug discovery--foundation in natural products.
    Singh SB; Barrett JF
    Biochem Pharmacol; 2006 Mar; 71(7):1006-15. PubMed ID: 16412984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chapter 1. Approaches to discovering novel antibacterial and antifungal agents.
    Donadio S; Monciardini P; Sosio M
    Methods Enzymol; 2009; 458():3-28. PubMed ID: 19374977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Opportunistic pathogen Candida glabrata and the mechanisms of its resistance to antifungal drugs].
    Berila N; Subík J
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):67-79. PubMed ID: 20586168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbial transformation of trichostatin A to 2,3-dihydrotrichostatin A.
    Park JW; Park SR; Han AR; Ban YH; Yoo YJ; Kim EJ; Kim E; Yoon YJ
    J Nat Prod; 2011 May; 74(5):1272-4. PubMed ID: 21504214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.